Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.54 |
| ▸ | KEAP1 | Q14145 | 3/20 | 0.53 |
| ▸ | SLC9A1 | P19634 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 5/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 5/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | TDO2 | P48775 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30764982 | 0.98 | KDM4E (0.53) | NPC1KDM4EL3MBTL1HCAR3KEAP1 | |
| SCHEMBL922757 | 0.84 | SLC9A1 (0.53) | NPC1KDM4EL3MBTL1HCAR3KEAP1 | |
| SCHEMBL24569545 | 0.81 | HCAR3 (0.45) | NPC1KDM4EHCAR3KEAP1SLC9A1 | |
| SCHEMBL24569481 | 0.78 | HCAR3 (0.40) | NPC1KDM4EL3MBTL1HCAR3KEAP1 | |
| SCHEMBL435034 | 0.78 | HCAR3 (0.56) | NPC1KDM4EHCAR3KEAP1SLC9A1 | |
| SCHEMBL19848724 | 0.78 | KDM4E (0.56) | NPC1KDM4EL3MBTL1MAPTSMN1; SMN2 | |
| SCHEMBL19911583 | 0.77 | KDM4E (0.51) | NPC1KDM4EL3MBTL1HCAR3HPGD | |
| SCHEMBL24569522 | 0.77 | HCAR3 (0.39) | NPC1KDM4EL3MBTL1HCAR3KEAP1 | |
| SCHEMBL19848597 | 0.77 | HCAR3 (0.60) | NPC1KDM4EL3MBTL1HCAR3SLC9A1 | |
| SCHEMBL1133392 | 0.76 | RAB9A (0.56) | NPC1KDM4EHCAR3KEAP1SLC9A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3416948-B1 | INDACENE BEARING SULFONYLUREAS AS ANTI-INFLAMMATORY AGENTS | UNIV QUEENSLAND (AU) | 2024-07-24 | — | — | EP | claimed |
| CN-106558534-B | Structure and method for interconnection | 台湾积体电路制造股份有限公司 | 2020-07-31 | — | — | CN | claimed |
| CN-106653681-B | Autoregistration interconnection structure and method | 台湾积体电路制造股份有限公司 | 2019-08-02 | — | — | CN | claimed |
| US-9818690-B2 | Self-aligned interconnection structure and method | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2017-11-14 | — | — | US | claimed |
| US-20170125340-A1 | Self-Aligned Interconnection Structure and Method | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2017-05-04 | — | — | US | claimed |
| US-9627215-B1 | Structure and method for interconnection | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2017-04-18 | — | — | US | claimed |
| US-20170092580-A1 | Structure and Method for Interconnection | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD (TW) | 2017-03-30 | — | — | US | claimed |
| US-12616018-B2 | Graphene barrier layer of interconnect structure | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2026-04-28 | — | — | US | disclosed |
| WO-2025245484-A1 | FOXN1 ACTIVATORS | THYMOFOX INC. (US) | 2025-11-27 | — | — | WO | disclosed |
| US-12315811-B2 | Graphene barrier layer for reduced contact resistance | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2025-05-27 | — | — | US | disclosed |
| US-12211788-B2 | Hybrid interconnect structure for self aligned via | TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) | 2025-01-28 | — | — | US | disclosed |
| CN-119118879-A | Blue light prevention cornea contact lens for controlling myopia | 凯乐康药业(江苏)有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240379559-A1 | GRAPHENE-ASSISTED LOW-RESISTANCE INTERCONNECT STRUCTURES AND METHODS OF FORMATION THEREOF | TAIWAN SEMICONDUCTOR MANUFACTURING CO., LTD. (TW) | 2024-11-14 | — | — | US | disclosed |
| WO-2005092899-A1 | INHIBITORS OF HISTONE DEACETYLASE | METHYLGENE INC. (CA) | 2005-10-06 | — | — | WO | disclosed |
| CN-1671379-A | Hydrazinopyrazole derivatives and their use as therapeutic agents | QUADRA LOGIC TECH INC (CA) | 2005-09-21 | — | — | CN | disclosed |
| EP-1450791-A1 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS | Kinetek Pharmaceuticals, Inc. (CA) | 2004-09-01 | — | — | EP | disclosed |
| WO-2003045379-A1 | HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS | KINETEK PHARMACEUTICALS, INC. (CA) | 2003-06-05 | — | — | WO | disclosed |
| US-20030060453-A1 | Pyrazole compounds | DERMIRA (CANADA), INC. | 2003-03-27 | — | — | US | disclosed |
| EP-0845026-A1 | MULTICOMPONENT SYSTEM FOR USE WITH DETERGENT SUBSTANCES | CALL, Hans-Peter Dr. (DE) | 1998-06-03 | — | — | EP | disclosed |
| WO-1997048786-A1 | MULTICOMPONENT SYSTEM FOR USE WITH DETERGENT SUBSTANCES | CALL HANS PETER (DE) | 1997-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616018-B2 | Graphene barrier layer of interconnect structure | CTCF, EPCAM, ICOSLG | NPC1 2549/4885KDM4E 725/4885L3MBTL1 3625/4885 |
| US-20030060453-A1 | Pyrazole compounds | CCNC, MKI67, CDC25C | NPC1 2227/4885KDM4E 1067/4885L3MBTL1 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.